The medical device company will unveil its latest prototypes of RFID-enabled surgical instruments developed in partnership with Xerafy Ltd.
As a result of months-long research and development efforts by Novo Surgical’s engineering and quality control teams, and using patented Xerafy RFID technology, Novo Surgical is now ready to unveil its first-generation of RFID-enabled surgical instrument prototypes at this year’s IAHCSMM 2017 conference in Nashville, Tennessee, taking place from May 7 through 9.
“We’re excited to present our first-generation of smart instruments developed in collaboration with Xerafy,” said Abed Moiduddin, Vice-President of Business Development at Novo Surgical. “Novo customers have demonstrated a strong interest in these next generation devices, and while our de-velopment efforts are ongoing, we couldn’t be happier than to partner with Xerafy, a pioneer in RFID technologies for healthcare environments.”
Dennis Khoo, Xerafy’s CEO, adds, “Our development cooperation with Novo Surgical is a signifi-cant step towards our vision of seamless tracking in healthcare. By integrating Xerafy’s technology into the very design of instruments, Novo Surgical is transforming ‘next’ into ‘now’.”
Xerafy developed and validated its healthcare-proof RFID technology over the years with UHF RFID tags and the design-in concept for surgical instruments — both patented by Xerafy. Following de-ployment of RFID-enabled surgical instrument tracking, Rigshospitalet in Denmark estimated it saved 31,000 hours a year in OR procedures alone.
RFID tracking comes with unique capabilities and benefits, compared to procedures such as man-ual counting or visual identification systems, making it the new standard for hospitals. From auto-mated tracking and tracing that reduces errors and avoids loss of equipment, to storing large amounts of user data like instrument location, history and sterilization, RFID and “smart” instru-ments result in reduced errors, decreased loss of surgical instruments, increased visibility and effi-ciency, superior demand forecasting and ultimately improved patient outcomes.
The RFID-enabled smart surgical instruments will be on display at Novo Surgical’s booth #1010 at the IAHCSMM Annual Conference and Expo with demonstrations of the RFID tracking workflow available in Xerafy’s booth #1217.
Attend the Novo Surgical presentations on the show floor and earn 0.5 CE credits. “Visual In-spection vs. Validated IFUs: An ‘Invisible’ Patient Safety Issue,” will be presented on Monday, May 8th, from 3:30 to 4:00 pm and again on Tuesday, May 9th, from 9:30 to 10:00 am at Novo Surgical’s booth #1010. These presentations will explore the critical patient safety implica-tions of relying on instructions for use for medical devices with cleaning instructions that have not been validated by independent laboratories to be effective.
About Novo Surgical, Inc.:
Novo Surgical, Inc., is a medical device company offering a comprehensive line of general and spe-cialty surgical instruments to healthcare providers worldwide. The company’s portfolio contains more than 12,000 instruments across all surgical specialties, including orthopedics, spine, cardio-thoracic, plastic, sinus, ophthalmology, gynecology, arthroscopy, laparoscopy and microsurgery. The company focuses on streamlining its supply chain to provide industry-leading values in the market. Novo Surgical also offers custom instrument design and manufacture.
Contact: Abed Moiduddin, VP Marketing & Business Development
About Xerafy Ltd.:
Xerafy works closely with operating rooms, central sterile supply departments, sterile processing departments, medical distributors, and surgical instrument manufacturers to deliver real time hospi-tal tracking. Our mission is to support medical standards and streamline the management process, enabling hospitals to track, locate and manage assets in real time. Xerafy is headquartered in Hong Kong with offices in the U.S., UK and China.
Contact: Michel Gillmann, Marketing Director